Tag Archives: also called X-hapten. CD15 is expressed on greater than 95% of granulocytes including neutrophils and eosinophils and to a varying degree on monodytes

Background Hepatic resection is currently still the best choice of therapeutic strategies for liver cancer, but the long-term survival rate after surgery is unsatisfactory. After the completion of surgical intervention, patients will be included in a 3-year follow-up program. Discussion … Continue reading →